NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)
Clinical trial NCT04442230 · TERMINATED
Trial details
- NCT number
- NCT04442230
- Sponsor
- Altimmune, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-10
- Primary completion
- 2021-02-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.